Can I Take CoQ10 with Sermorelin?

  • CoQ10 interactions flagged by NCCIH / warfarin, insulin, some cancer treatments [1]
  • CoQ10 safety / no serious side effects reported; observed safe level 1,200 mg/day [1][7]
  • CoQ10 doses in trials / 50 mg twice daily up to 600 mg/day ubiquinol [8][9]
  • Blood pressure effect / not significant in pooled randomized trials [10]
  • Sermorelin today / compounded, not FDA-approved; Geref withdrawn in 2009 [4][11]

Is there a known interaction between CoQ10 and sermorelin?

The two are described very differently. CoQ10 is a substance the body makes, with the highest levels in the heart, liver, kidneys and pancreas, and it is sold in the United States as a dietary supplement [1]. Its described jobs are electron transport in mitochondrial energy production and lipid-phase antioxidant activity [12]. Sermorelin is a peptide that acts on the pituitary to trigger the body's own growth hormone release; it is not growth hormone itself [3].

Sermorelin: a peptide with no current FDA approval

Sermorelin is a 29-amino-acid analogue of human growth hormone-releasing hormone, the shortest synthetic peptide with the full biological activity of GHRH [3]. In healthy men given GHRH(1-29)-NH2 intravenously, the peptide was eliminated quickly, yet growth hormone levels stayed raised for about 3 hours [13].

Sermorelin was once approved as Geref under two applications: a 0.05 mg/ampule product for testing the pituitary's ability to secrete growth hormone, approved December 28, 1990, and 0.5 mg and 1 mg vials for treating idiopathic growth hormone deficiency in children with growth failure, approved September 26, 1997 [4]. The manufacturer discontinued both in 2008 and asked FDA to withdraw the applications, which FDA did effective June 18, 2009 [4]. In March 2013 FDA determined that Geref was not withdrawn for reasons of safety or effectiveness [4]. The approved uses never included adults, anti-aging, weight loss or athletic performance [4].

With the approval gone, sermorelin products sold in the US today are compounded, and compounded drugs are not FDA-approved: FDA does not review their safety, effectiveness or quality before they are marketed [11]. Sermorelin is not on FDA's list of bulk substances that may present significant safety risks when compounded [14]. HealthRX.com offers sermorelin by prescription.

What CoQ10 is, and what its own data show

CoQ10 is naturally present in the body and is sold as a supplement; a Drugs@FDA search for ubidecarenone returned no approved drug application [1][2].

NCCIH reports no serious side effects, with mild effects such as insomnia or digestive upset possible [1]. A formal risk assessment found that nausea and other stomach effects were no more common at 1,200 mg/day than at 60 mg/day, and set 1,200 mg/day as the observed safe level; data above that dose are not sufficient to conclude safety [7].

Doses used in the trials cited on this page were 100 mg/day for 4 weeks in a warfarin study [6], 50 mg twice daily for 30 days [8], 400 mg/day for 8 weeks [16], and 600 mg/day as ubiquinol for 8 weeks [9]. These are study doses, not recommended doses.

NCCIH also states that CoQ10 may interact with warfarin and with insulin, and may not be compatible with some types of cancer treatment; its page gives no detail on the insulin or cancer-treatment points [1].

CoQ10 and warfarin: what the reports show

Case reports describe a reduced warfarin response with CoQ10. A 72-year-old woman on warfarin became less responsive while taking CoQ10 and returned to her previous response when she stopped it; CoQ10 is chemically similar to vitamin K, which was offered as a possible explanation [5]. A 1994 Lancet letter is titled 'Reduced effect of warfarin caused by ubidecarenone' [17].

The best controlled human data point the other way. In a randomized, double-blind, placebo-controlled crossover trial, 24 outpatients on stable long-term warfarin took CoQ10 100 mg/day for 4 weeks; INR stayed stable and the geometric mean warfarin dose was 36.5 mg/week on CoQ10 versus 36.0 mg/week on placebo, with 21 patients completing [6]. So the case reports suggest it can happen in some people, while the controlled trial at 100 mg/day found no change in INR control or warfarin dose [5][6].

CoQ10 and blood pressure

CoQ10 does not appear to be a meaningful blood pressure treatment. Cochrane pooled two randomized trials in 50 people with hypertension and found a systolic change of -3.68 mmHg (95% CI -8.86 to 1.49) and a diastolic change of -2.03 mmHg (95% CI -4.86 to 0.81), neither significant, with moderate-quality evidence of no clinically significant effect [10]. NCCIH says CoQ10 probably has no meaningful effect on blood pressure [1].

What the sermorelin safety data cover

The safety data for sermorelin come mainly from children with growth hormone deficiency. In a 1-year, open-label, multicenter study of 110 previously untreated prepubertal children, no adverse changes appeared in general biochemistry or hormone tests, fasting glucose did not change, IGF-I was not excessively raised, and the peptide was well tolerated overall [19]. That is the population and duration the data cover; it is not an adult safety database.

CoQ10's known interaction flags are warfarin, insulin and some cancer treatments [1]. Those are CoQ10's own interactions, not interactions with sermorelin.

Frequently asked questions

Can I take CoQ10 with sermorelin?
We found no published study that tested CoQ10 and sermorelin together, so whether they interact has not been established. CoQ10 may interact with warfarin and insulin, and it may not be compatible with some types of cancer treatment [1]; sermorelin has no current FDA-approved product or label [4][11].
Does CoQ10 lower blood pressure?
Not significantly in the pooled randomized trials. Cochrane combined 2 trials in 50 people with hypertension and found a systolic change of -3.68 mmHg (95% CI -8.86 to 1.49) and a diastolic change of -2.03 mmHg (95% CI -4.86 to 0.81) [10]. NCCIH says CoQ10 probably has no meaningful effect on blood pressure [1].
Is CoQ10 safe at supplement doses?
NCCIH reports no serious side effects, with mild insomnia or digestive upset possible [1]. A risk assessment found nausea and other stomach effects no more common at 1,200 mg/day than at 60 mg/day and set 1,200 mg/day as the observed safe level; data above that are not enough to conclude safety [7].
Does CoQ10 interact with statins?
No harmful interaction has been found. CoQ10 has been tested as a possible fix for statin muscle symptoms with conflicting results: two meta-analyses of 302 and 321 patients and a randomized trial of 41 people with confirmed statin muscle pain found no benefit [22][23][9], one 12-trial meta-analysis of 575 patients reported less muscle pain [24], and NCCIH says the overall evidence does not support it [1].
Is sermorelin FDA-approved?
Not today. Geref was approved for a pituitary diagnostic test and for growth hormone deficiency in children, then discontinued in 2008 with both approvals withdrawn effective June 18, 2009 [4]. Sermorelin sold now is compounded, and compounded drugs are not FDA-approved [11].
Show all 24 referencesHide references
  1. Coenzyme Q10 | NCCIH.
  2. Drugs@FDA: FDA-Approved Drugs.
  3. Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-57.
  4. Federal Register :: Request Access.
  5. Landbo C, Almdal TP. [Interaction between warfarin and coenzyme Q10]. Ugeskr Laeger. 1998;160(22):3226-7.
  6. Engelsen J, Nielsen JD, Hansen KF. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. Ugeskr Laeger. 2003;165(18):1868-71.
  7. Hathcock JN, Shao A. Risk assessment for coenzyme Q10 (Ubiquinone). Regul Toxicol Pharmacol. 2006;45(3):282-8.
  8. Skarlovnik A, Janić M, Lunder M, Turk M, Šabovič M. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Med Sci Monit. 2014;20:2183-8.
  9. Taylor BA, Lorson L, White CM, Thompson PD. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy. Atherosclerosis. 2015;238(2):329-35.
  10. Ho MJ, Li EC, Wright JM. Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension. Cochrane Database Syst Rev. 2016;3(3):CD007435.
  11. Official web page.
  12. Garrido-Maraver J, Cordero MD, Oropesa-Avila M, Vega AF, de la Mata M, Pavon AD, et al. Clinical applications of coenzyme Q10. Front Biosci (Landmark Ed). 2014;19(4):619-33.
  13. Wilton P, Chardet Y, Danielson K, Widlund L, Gunnarsson R. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-5.
  14. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
  15. Kalén A, Appelkvist EL, Dallner G. Age-related changes in the lipid compositions of rat and human tissues. Lipids. 1989;24(7):579-84.
  16. Dohlmann TL, Kuhlman AB, Morville T, Dahl M, Asping M, Orlando P, et al. Coenzyme Q10 Supplementation in Statin Treated Patients: A Double-Blinded Randomized Placebo-Controlled Trial. Antioxidants (Basel). 2022;11(9).
  17. Spigset O. Reduced effect of warfarin caused by ubidecarenone. Lancet. 1994;344(8933):1372-3.
  18. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, et al. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21(4):297-306.
  19. Thorner M, Rochiccioli P, Colle M, Lanes R, Grunt J, Galazka A, et al. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group. J Clin Endocrinol Metab. 1996;81(3):1189-96.
  20. Corpas E, Harman SM, Piñeyro MA, Roberson R, Blackman MR. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-5.
  21. Langsjoen PH, Langsjoen AM. Comparison study of plasma coenzyme Q10 levels in healthy subjects supplemented with ubiquinol versus ubiquinone. Clin Pharmacol Drug Dev. 2014;3(1):13-7.
  22. Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, et al. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2015;90(1):24-34.
  23. Kennedy C, Köller Y, Surkova E. Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis. Atherosclerosis. 2020;299:1-8.
  24. Qu H, Guo M, Chai H, Wang WT, Gao ZY, Shi DZ. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2018;7(19):e009835.
Can I take CoQ10 with sermorelin: evidence summary chart
Image: HealthRX.com. Full can I take CoQ10 with sermorelin guide and sources at healthrx.com/supplements-sermorelin.